Agilent stock price gained 0

Agilent stock price gained 0.9% to $145.60, supported by positive sentiment in the biotech supply chain. Chartists point to a bullish cup-and-handle formation, which could signal a breakout above the $148 resistance if momentum continues. We then compared Agilent Technologies' net income growth with the industry and we're pleased to see that the company's growth figure is higher when compared with the industry which has a growth rate of 2.0% in the same 5-year period. Agilent Technologies ( NYSE:A - Get Free Report ) last released its earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, hitting analysts' consensus estimates of $1.37. The firm had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The firm's revenue for the quarter was up 10.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.32 earnings per share. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Equities research analysts anticipate that Agilent Technologies will post 5.58 EPS for the current year. Institutional Investors Weigh In On Agilent Technologies October’s Top 5 Stocks Poised for Big Breakouts Hedge funds and other institutional investors have recently made changes to their positions in the business. Mirae Asset Global Investments Co. Ltd. grew its position in shares of Agilent Technologies by 13.5% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 36,674 shares of the medical research company's stock valued at $4,279,000 after purchasing an additional 4,362 shares during the last quarter. Assenagon Asset Management S.A. grew its position in Agilent Technologies by 8.3% during the first quarter. Assenagon Asset Management S.A. now owns 30,827 shares of the medical research company's stock worth $3,606,000 after buying an additional 2,371 shares in the last quarter. Alps Advisors Inc. grew its position in Agilent Technologies by 29.5% during the first quarter. Alps Advisors Inc. now owns 13,358 shares of the medical research company's stock worth $1,563,000 after buying an additional 3,040 shares in the last quarter. D.A. Davidson & CO. grew its position in Agilent Technologies by 30.4% during the first quarter. D.A. Davidson & CO. now owns 9,474 shares of the medical research company's stock worth $1,108,000 after buying an additional 2,207 shares in the last quarter. Finally, LGT Capital Partners LTD. lifted its stake in Agilent Technologies by 7.6% during the first quarter. LGT Capital Partners LTD. now owns 768,252 shares of the medical research company's stock worth $89,870,000 after purchasing an additional 54,302 shares during the period. About Agilent Technologies ( Get Free Report ) Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. See Also Five stocks we like better than Agilent Technologies How to Invest in Biotech Stocks Oil Set to Rebound? 3 Stocks That Win if Crude Climbs Ride Out The Recession With These Dividend Kings The New Brain of Business: UiPath Is Creating an AI Revolution How to Invest in the Best Canadian Stocks Buy The Dip Opportunity: Paychex Signals Rebound After Sell-Off This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]. Should You Invest $1,000 in Agilent Technologies Right Now? Before you consider Agilent Technologies, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list. While Agilent Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks Here The Next 7 Blockbuster Stocks for Growth Investors Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks. Get This Free Report Agilent stock price reached $146.15, extending gains for the third consecutive day. This uptick aligns with optimism ahead of quarterly earnings, where analysts forecast EPS growth of 8% year-over-year, largely from recurring service contracts.